Literature DB >> 11315609

Seeking a radiobiological explanation for thyroid stunning.

M Medvedec.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11315609     DOI: 10.1007/s002590000466

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


× No keyword cloud information.
  9 in total

1.  Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma.

Authors:  F A Leger; M Izembart; F Dagousset; L Barritault; G Baillet; A Chevalier; J Clerc
Journal:  Eur J Nucl Med       Date:  1998-03

2.  74 MBq radioiodine 131I does not prevent uptake of therapeutic doses of 131I (i.e. it does not cause stunning) in differentiated thyroid cancer.

Authors:  I R McDougall
Journal:  Nucl Med Commun       Date:  1997-06       Impact factor: 1.690

3.  Does thyroid stunning exist? A model with benign thyroid disease.

Authors:  O Sabri; M Zimny; M Schreckenberger; A Meyer-Oelmann; P Reinartz; U Buell
Journal:  Eur J Nucl Med       Date:  2000-11

4.  Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients.

Authors:  R K Jeevanram; D H Shah; S M Sharma; R D Ganatra
Journal:  Int J Rad Appl Instrum B       Date:  1986

Review 5.  Radiation dose-rate: a factor of importance in radiobiology and radiotherapy.

Authors:  E J Hall
Journal:  Br J Radiol       Date:  1972-02       Impact factor: 3.039

6.  Absence of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.

Authors:  S P Cholewinski; K S Yoo; P S Klieger; R E O'Mara
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

7.  Radioiodine uptake in thyroid cancer patients after diagnostic application of low-dose 131I.

Authors:  D Huić; M Medvedec; D Dodig; S Popović; D Ivancević; Z Pavlinovic; M Zuvic
Journal:  Nucl Med Commun       Date:  1996-10       Impact factor: 1.690

8.  Determination of small objects from pinhole scintigrams.

Authors:  D Grosev; M Medvedec; S Loncarić; M Zuvić; D Dodig; T Smuc
Journal:  Nucl Med Commun       Date:  1998-07       Impact factor: 1.690

9.  Radioiodine therapy for well-differentiated thyroid cancer: a quantitative dosimetric evaluation for remnant thyroid ablation after surgery.

Authors:  A M Samuel; B Rajashekharrao
Journal:  J Nucl Med       Date:  1994-12       Impact factor: 10.057

  9 in total
  2 in total

1.  Decreased radioiodine uptake of FRTL-5 cells after (131)I incubation in vitro: molecular biological investigations indicate a cell cycle-dependent pathway.

Authors:  Birgit Meller; Erzsébet Gaspar; Wibke Deisting; Barbara Czarnocka; Manfred Baehre; Björn E Wenzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-29       Impact factor: 9.236

2.  Statistical and radiobiological analysis of the so-called thyroid stunning.

Authors:  Stephan Walrand; Michel Hesse; François Jamar
Journal:  EJNMMI Res       Date:  2015-11-19       Impact factor: 3.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.